Literature DB >> 12906772

Immune disorders caused by defects in the caspase cascade.

Jennifer M Puck1, Shigui Zhu.   

Abstract

In the immune system, lymphocyte activation by antigen is followed by cell proliferation and induction of effector functions. Subsequently, physiologic cell-death signals are induced, resulting in removal of expanded effector-cell populations, to maintain homeostasis. Caspases are intracellular participants in both activation responses and cell death by apoptosis. Targets of caspases include inflammatory activators and also other members of the caspase family that mediate apoptosis. Caspase-8 and caspase-10 participate in the protease cascade following cell surface CD95 engagement by its ligand. Humans with defects in these caspases were initially evaluated for the autoimmune lymphoproliferative syndrome because of their spleen and lymph node enlargement. Although both caspase-8- and caspase-10-deficient individuals had impaired apoptosis, those with caspase-8 deficiency, who also had immunodeficiency, had additional defects in activation of lymphocytes and natural killer cells. These disorders help to define the importance and specificity of the caspase proteases in intracellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906772     DOI: 10.1007/s11882-003-0070-1

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  31 in total

1.  A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Authors:  N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

Review 2.  IAP family proteins--suppressors of apoptosis.

Authors:  Q L Deveraux; J C Reed
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

Review 3.  Caspases: killer proteases.

Authors:  D W Nicholson; N A Thornberry
Journal:  Trends Biochem Sci       Date:  1997-08       Impact factor: 13.807

4.  Mechanism of XIAP-mediated inhibition of caspase-9.

Authors:  Eric N Shiozaki; Jijie Chai; Daniel J Rigotti; Stefan J Riedl; Pingwei Li; Srinivasa M Srinivasula; Emad S Alnemri; Robert Fairman; Yigong Shi
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

5.  Defects in regulation of apoptosis in caspase-2-deficient mice.

Authors:  L Bergeron; G I Perez; G Macdonald; L Shi; Y Sun; A Jurisicova; S Varmuza; K E Latham; J A Flaws; J C Salter; H Hara; M A Moskowitz; E Li; A Greenberg; J L Tilly; J Yuan
Journal:  Genes Dev       Date:  1998-05-01       Impact factor: 11.361

Review 6.  Mechanisms of caspase activation and inhibition during apoptosis.

Authors:  Yigong Shi
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

7.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

8.  Differential requirement for caspase 9 in apoptotic pathways in vivo.

Authors:  R Hakem; A Hakem; G S Duncan; J T Henderson; M Woo; M S Soengas; A Elia; J L de la Pompa; D Kagi; W Khoo; J Potter; R Yoshida; S A Kaufman; S W Lowe; J M Penninger; T W Mak
Journal:  Cell       Date:  1998-08-07       Impact factor: 41.582

9.  Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9.

Authors:  K Kuida; T F Haydar; C Y Kuan; Y Gu; C Taya; H Karasuyama; M S Su; P Rakic; R A Flavell
Journal:  Cell       Date:  1998-08-07       Impact factor: 41.582

10.  Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

Authors:  Martin R Sprick; Eva Rieser; Heiko Stahl; Anne Grosse-Wilde; Markus A Weigand; Henning Walczak
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

View more
  2 in total

Review 1.  The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.

Authors:  Frédéric Rieux-Laucat; Aude Magérus-Chatinet; Bénédicte Neven
Journal:  J Clin Immunol       Date:  2018-06-17       Impact factor: 8.317

2.  Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.

Authors:  Shigui Zhu; Amy P Hsu; Marla M Vacek; Lixin Zheng; Alejandro A Schäffer; Janet K Dale; Joie Davis; Roxanne E Fischer; Stephen E Straus; Donna Boruchov; Frank T Saulsbury; Michael J Lenardo; Jennifer M Puck
Journal:  Hum Genet       Date:  2006-01-31       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.